NO306294B1 - FremgangsmÕte for fremstilling av azetidinoner - Google Patents

FremgangsmÕte for fremstilling av azetidinoner

Info

Publication number
NO306294B1
NO306294B1 NO960083A NO960083A NO306294B1 NO 306294 B1 NO306294 B1 NO 306294B1 NO 960083 A NO960083 A NO 960083A NO 960083 A NO960083 A NO 960083A NO 306294 B1 NO306294 B1 NO 306294B1
Authority
NO
Norway
Prior art keywords
substituted
pct
beta
amino
azetidinones
Prior art date
Application number
NO960083A
Other languages
English (en)
Other versions
NO960083L (no
NO960083D0 (no
Inventor
Tiruvettipuram K Thiruvengadam
Timothy Mcallister
Chou-Hong Tann
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22217215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO306294(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO960083D0 publication Critical patent/NO960083D0/no
Publication of NO960083L publication Critical patent/NO960083L/no
Publication of NO306294B1 publication Critical patent/NO306294B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO960083A 1993-07-09 1996-01-08 FremgangsmÕte for fremstilling av azetidinoner NO306294B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8935793A 1993-07-09 1993-07-09
PCT/US1994/007291 WO1995001961A1 (en) 1993-07-09 1994-07-01 Process for the synthesis of azetidinones

Publications (3)

Publication Number Publication Date
NO960083D0 NO960083D0 (no) 1996-01-08
NO960083L NO960083L (no) 1996-03-04
NO306294B1 true NO306294B1 (no) 1999-10-18

Family

ID=22217215

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960083A NO306294B1 (no) 1993-07-09 1996-01-08 FremgangsmÕte for fremstilling av azetidinoner

Country Status (21)

Country Link
US (1) US5728827A (no)
EP (1) EP0707567B1 (no)
JP (1) JP2840452B2 (no)
KR (1) KR0176001B1 (no)
CN (1) CN1071745C (no)
AT (1) ATE205475T1 (no)
AU (1) AU681419B2 (no)
CA (1) CA2166784C (no)
CZ (1) CZ7696A3 (no)
DE (1) DE69428280T2 (no)
DK (1) DK0707567T3 (no)
ES (1) ES2160125T3 (no)
FI (1) FI960095A0 (no)
HU (1) HUT73237A (no)
MX (1) MX9405152A (no)
NO (1) NO306294B1 (no)
NZ (1) NZ268798A (no)
PL (1) PL312502A1 (no)
PT (1) PT707567E (no)
SK (1) SK3796A3 (no)
WO (1) WO1995001961A1 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
AR025144A1 (es) * 1998-12-07 2002-11-13 Schering Corp Proceso para preparar azetidinonas, proceso para preparar compuestos intermediarios asi como dichos compuestos intermediarios
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
AU4343500A (en) * 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
PT1413331E (pt) * 2001-01-26 2007-12-18 Schering Corp Combinações do activador do receptor activado por proliferador do peroxisoma (ppar) fenofibrato e inibidor da absorção de esterol para indicações vasculares.
CN1275949C (zh) * 2001-03-28 2006-09-20 先灵公司 2-吖丁啶酮中间体化合物的对映体选择性合成
ATE345793T1 (de) * 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US20030204096A1 (en) * 2002-03-25 2003-10-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) * 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
WO2004081002A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7208486B2 (en) * 2003-03-07 2007-04-24 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
CA2550215A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
JP2007516287A (ja) * 2003-12-23 2007-06-21 メルク エンド カムパニー インコーポレーテッド 抗高コレステロール血症化合物
EP1723414A4 (en) * 2004-01-16 2008-03-26 Merck & Co Inc NPC1L1 (NPC3) AND METHOD FOR IDENTIFYING ITS LIGANDS
DE102004025071B4 (de) * 2004-05-21 2006-12-21 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
NZ551413A (en) 2004-05-21 2009-07-31 Sanofi Aventis Deutschland Method for producing 1,4-diphenyl azetidinone derivatives
MX2007007473A (es) * 2004-12-20 2007-09-04 Schering Corp Procedimiento para la sintesis de azetidinonas.
MX2008000115A (es) * 2005-06-20 2008-03-18 Schering Corp Derivados de piperidina utiles como antagonistas de histamina h3.
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
WO2007100807A2 (en) 2006-02-24 2007-09-07 Schering Corporation Npc1l1 orthologues
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
WO2008030382A1 (en) * 2006-09-05 2008-03-13 Schering Corporation Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
WO2008032338A2 (en) * 2006-09-11 2008-03-20 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe and its intermediates
CN101679236B (zh) 2007-01-24 2013-03-06 克尔克公司 依泽替米贝的制备方法和其的衍生物
WO2010113175A2 (en) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN104803858B (zh) * 2014-01-23 2019-03-01 东莞东阳光科研发有限公司 一种制备四丁基氟化铵三水合物的方法
IL295281A (en) 2020-02-07 2022-10-01 Gasherbrum Bio Inc Heterocyclic glp-1 agonists

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333268A1 (en) * 1988-03-18 1989-09-20 Merck & Co. Inc. Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
US4983597A (en) * 1989-08-31 1991-01-08 Merck & Co., Inc. Beta-lactams as anticholesterolemic agents
US5085473A (en) * 1990-10-09 1992-02-04 Yuhe Yang Air actuated car curtain device
HUT67341A (en) * 1991-07-23 1995-03-28 Schering Corp Substituted beta-lactam compounds useful as hypocholesterolemic agents, pharmaceutical compositions containing the same and process for the production thereof

Also Published As

Publication number Publication date
EP0707567A1 (en) 1996-04-24
EP0707567B1 (en) 2001-09-12
SK3796A3 (en) 1997-02-05
CA2166784C (en) 2001-12-11
JP2840452B2 (ja) 1998-12-24
HU9503748D0 (en) 1996-02-28
ES2160125T3 (es) 2001-11-01
CN1126989A (zh) 1996-07-17
PT707567E (pt) 2002-01-30
NZ268798A (en) 1997-01-29
CA2166784A1 (en) 1995-01-19
FI960095A (fi) 1996-01-09
MX9405152A (es) 1995-01-31
NO960083L (no) 1996-03-04
AU681419B2 (en) 1997-08-28
CZ7696A3 (en) 1996-04-17
AU7214694A (en) 1995-02-06
CN1071745C (zh) 2001-09-26
FI960095A0 (fi) 1996-01-09
HUT73237A (en) 1996-07-29
KR960703853A (ko) 1996-08-31
ATE205475T1 (de) 2001-09-15
DE69428280T2 (de) 2002-06-13
KR0176001B1 (ko) 1999-03-20
NO960083D0 (no) 1996-01-08
DK0707567T3 (da) 2001-11-26
PL312502A1 (en) 1996-04-29
JPH08507085A (ja) 1996-07-30
US5728827A (en) 1998-03-17
DE69428280D1 (de) 2001-10-18
WO1995001961A1 (en) 1995-01-19

Similar Documents

Publication Publication Date Title
NO306294B1 (no) FremgangsmÕte for fremstilling av azetidinoner
BG108168A (en) Enantioselective synthesis of azetidinone intermediate compounds
PL318100A1 (en) 2-[(dihydro) pyrazolyl-3'-oxymethylene]anilides, method of obtaining them and their application
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
DE69433984D1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
IL172973A (en) Process for the preparation of (4s, 5r) - n - boc - 2 - (2' 4 - dimethoxyphenyl) - 4 - isobutyl - 1 - oxazolidine - 5 - carboxylic acid
AU4387296A (en) Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
NZ331875A (en) Asymmetric synthesis of R-alpha-propyl-piperonyl amine and its analogs
BG104243A (en) Method for the synthesis of quinoline derivatives
YU12000A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
MY133666A (en) Enzymatic process for stereoselective preparation of therapeutic amides
SI1307436T1 (en) Process for the preparation of baccatin iii derivatives
EP1134213A3 (en) Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides
IN190402B (no)
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
MXPA03009723A (es) Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo.
IL133410A0 (en) Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
NZ516209A (en) Indoloazepines as vasopressin receptor antagonists
ZA961897B (en) 6,7-substituted-2-aminotetralines and use thereof
YU37902A (sh) Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3- benzazocini i njihova primena kao lekova

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2001